Today's case centred around a classic internal
medicine differential diagnosis for multilineage cytopenias. The patient is an elderly man with cirrhosis who presented with fatigue and lethargy. He was found to have a profound anemia, thrombocytopenia and leukopenia. He was admitted to the internal medicine
service wherein a bone marrow aspiration and biopsy was performed revealing
acute myelogenous leukemia.
The approach to the
differential diagnosis in this case is very important, as there are multiple
diagnostic entities that can produce this syndrome:
· Malignant processes (think of bone marrow
replacement with hematologic malignancies like leukemias, scar as in
myelofibrosis, or non-hematologic malignancies with a significant degree of
bone marrow infiltration).
· Cellular destruction (it is unusual for this to
cause trilineage cytopenias, but certainly anemia/thrombocycopenia combinations
are possible in diagnoses like HUS or TTP)
· Inflammatory/Autoimmune diseases like SLE can
lead to pancytopenia.
· Drug effects can be categorized into drugs that
are intentionally halting cellular maturation and production like
chemotherapeutic agents, and drugs that exhibit this as an idiosyncratic side
effect like phenytoin or Septra.
· Substrate deficiency – the example used during
morning report was B12 deficiency which can lead to megaloblastic anemia,
hypersegmented neutrophils on the blood film, and neurologic complications like
dorsal column dysfunction and peripheral neuropathies.
· Sequestration – Sequestration can happen in
tissues like the spleen and liver in conditions that produce portal
hypertension, such as cirrhosis. We
usually attribute thrombocytopenia to this condition, but it can certainly be
seen in other cell lines.
· Infections – viral infections like hepatitis B
can lead to aplastic anemia. HIV can
certainly lead to cytopenias. In immunocompromised hosts such as those with
advanced HIV, disseminated Mycobacterium
avium infections can replace bone
marrow leading to pancytopenias.
The physical
examination of a patient with these clinical entities can be very revealing:
· On vital signs – findings such as hypotension
or tachycardia can be revealing of a hyperdynamic cardiac output secondary to
anemia. Orthostatic changes would
suggest hypovolemia. Fever may suggest
an underlying malignant or infectious process.
· On general appearance – pallor or jaundice may
suggest anemia and/or hemolysis. It’s
also important to characterize the degree of distress the patient may
have. Rashes like patecheiae or purpura
may relate to the degree of thrombocytopenia.
Inside the mouth, gingival hyperplasia may occur with some variants of
leukemia.
· On cardiovascular examination, a flow murmur
over the tricuspid valve due to ramped up cardiac output from anemia may be
audible. In someone with cirrhosis,
signs of pulmonary hypertension (TR murmur, high JVP or CV waves, RV heave,
loud and/or palpable P2) may be related to portopulmonary hypertension.
· On abdominal examination, the liver size is
important, but splenomegaly is also very important. Generally, percussion of Traube’s space,
followed by Castell’s sign, followed by percussion using Nixon’s method
increase in specificity for splenomegaly.
Importantly, your physical examination is only around 80% sensitive for
splenomegaly meaning that you cannot rule
out splenomegaly on exam alone.
Abdominal ultrasound would be the mainstay of diagnostic tests for
splenomegaly.
Management of this
condition involves treatment of the underlying process (the leukemia). This typically involves chemotherapy, the
type and duration of which is a highly subspecialized field. It is unusual but
possible for leukemia to be present without circulating blasts, but they are
otherwise the hallmark of diagnosis.
In addition to
treating the leukemia, it is important to recognize the complications of
leukemia including bleeding from thrombocytopenia, disseminated intravascular
coagulation from some forms of leukemia, and infections as a result of
inadequate numbers and function of leukocytes.
Aside from some of these complications, the pathophysiologic process
leading to death from acute leukemias is the cytopenias themselves.
Image Credit: de.academic.ru
Further Reading:
Döhner, H., Weisdorf,
D. J., & Bloomfield, C. D. (2015). Acute myeloid leukemia. New England
Journal of Medicine, 373(12), 1136-1152.
Grover, S. A., Barkun,
A. N., & Sackett, D. L. (1993). Does this patient have splenomegaly?. Jama,
270(18), 2218-2221.
No comments:
Post a Comment